Established relationships with 6 of the top 10 Big Pharma.
Divi’s is engaged in Custom Synthesis of APIs and Intermediates for global innovator companies with a vast portfolio of products across diverse therapeutic areas.
Divi’s is competent in handling high energetic reactions with high potency to address unmet requirements of the Big Pharma customers.
Both the manufacturing units have undergone several EHS, Quality and Sustainability audits by several Big Pharma.
6 out of the top 10 Big Pharma Companies across US, EU and Japan are associated with Divi’s for more than 10 years.
Capable of handling highly hazardous / energetic reactions (Handling of NBL/Cyanide/metals)- Dedicated facilities for handling High pressure Rxs up to 20Kg/cm2, Cyanations & pyrophoric reactions.
Divi’s competent and qualified R&D team with over 325 scientists specialize in developing innovative processes and continuously optimize them to maintain competitive leadership position.
Divi’s manufacturing units have been inspected successfully many times by USFDA (recently in May 2018), EU authorities (Most recently in August 2017) and also by Japanese health authorities.
Segregated and dedicated production blocks for handling High Energetic Reactions, Azide Chemistry and Pressure Reactions.
Divi’s has Containment facility with closed handling systems like Glove boxes for charging, Isolators for offloading, Powder Transfer Systems and flexible isolators for changing filters and cleaning the utensils etc.